| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
Foguth Wealth Management, LLC.
|
2,035 |
3,690 |
81.33 |
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
First Nebraska Trust Co
|
|
66,544 |
|
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Flagship Wealth Advisors, Llc
|
2,013 |
1,969 |
-2.19 |
| 2026-06-01 |
13F-HR |
ALNY
/ Alnylam Pharmaceuticals
|
Caerus Investment Advisors, LLC
|
1,173 |
0 |
-100.00 |
| 2026-06-01 |
13F-HR |
SEEL
/ Seelos Therapeutics
|
Flagship Wealth Advisors, Llc
|
73 |
73 |
0.00 |
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Foguth Wealth Management, LLC.
|
1,910 |
1,896 |
-0.73 |
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Concorde Asset Management, LLC
|
3,807 |
3,088 |
-18.89 |
| 2026-06-01 |
13F-HR/A |
TEVA
/ Teva Pharmaceutical Industries Limited - Depositary Receipt
|
Nwi Management Lp
|
2,065,000 |
2,065,000 |
0.00 |
| 2026-06-01 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Nwi Management Lp
|
1,500 |
55,500 |
3,600.00 |
| 2026-06-01 |
13F-HR |
REGN
/ Regeneron Pharmaceuticals
|
Caerus Investment Advisors, LLC
|
1,639 |
1,666 |
1.65 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Financial Solutions Advisory Group, Inc.
|
|
1,444 |
|
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Financial Solutions Advisory Group, Inc.
|
|
2,482 |
|
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Integrated Investment Consultants, LLC
|
3,541 |
3,555 |
0.40 |
| 2026-06-01 |
SCHEDULE 13D/A |
QTTB
/ Q32 Bio
|
Orbimed Advisors Llc
|
2,252,987 |
4,127,987 |
83.22 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Flagship Wealth Advisors, Llc
|
1,497 |
1,259 |
-15.90 |
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Dala Group, LLC
|
|
1,966 |
|
| 2026-06-01 |
13F-HR |
TGTX
/ TG Therapeutics
|
First Nebraska Trust Co
|
|
7,000 |
|
| 2026-06-01 |
13F-HR |
MDGL
/ Madrigal Pharmaceuticals
|
Integrated Investment Consultants, LLC
|
567 |
568 |
0.18 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
First Nebraska Trust Co
|
|
6,933 |
|
| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
Integrated Investment Consultants, LLC
|
18,732 |
18,661 |
-0.38 |
| 2026-06-01 |
13F-HR |
ANIX
/ Anixa Biosciences
|
Concorde Asset Management, LLC
|
12,000 |
0 |
-100.00 |
| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
Flagship Wealth Advisors, Llc
|
2,160 |
700 |
-67.59 |
| 2026-06-01 |
13F-HR |
SRPT
/ Sarepta Therapeutics
|
Caerus Investment Advisors, LLC
|
18,222 |
9,854 |
-45.92 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Foguth Wealth Management, LLC.
|
679 |
659 |
-2.95 |
| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
Financial Solutions Advisory Group, Inc.
|
|
9,967 |
|
| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
First Nebraska Trust Co
|
|
5,959 |
|
| 2026-06-01 |
13F-HR/A |
NAMS
/ NewAmsterdam Pharma Company N.V.
|
Nwi Management Lp
|
702,000 |
702,000 |
0.00 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Concorde Asset Management, LLC
|
890 |
635 |
-28.65 |
| 2026-06-01 |
13F-HR |
ABT
/ Abbott Laboratories
|
Concorde Asset Management, LLC
|
2,021 |
1,990 |
-1.53 |
| 2026-06-01 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Nwi Management Lp
|
28,500 |
1,500 |
-94.74 |
| 2026-06-01 |
13F-HR |
BMRN
/ BioMarin Pharmaceutical
|
Caerus Investment Advisors, LLC
|
10,236 |
4,905 |
-52.08 |
| 2026-06-01 |
13F-HR |
LLY
/ Eli Lilly and
|
Caerus Investment Advisors, LLC
|
545 |
596 |
9.36 |
| 2026-06-01 |
13F-HR |
BINC
/ BlackRock ETF Trust II - iShares Flexible Income Active ETF
|
Concorde Asset Management, LLC
|
20,978 |
18,540 |
-11.62 |
| 2026-06-01 |
13F-HR |
VTRS
/ Viatris
|
Flagship Wealth Advisors, Llc
|
1,119 |
1,119 |
0.00 |
| 2026-06-01 |
13F-HR/A |
NAMS
/ NewAmsterdam Pharma Company N.V.
|
Nwi Management Lp
|
|
702,000 |
|
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Integrated Investment Consultants, LLC
|
12,189 |
11,331 |
-7.04 |
| 2026-06-01 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Caerus Investment Advisors, LLC
|
3,017 |
3,022 |
0.17 |
| 2026-06-01 |
13F-HR/A |
TEVA
/ Teva Pharmaceutical Industries Limited - Depositary Receipt
|
Nwi Management Lp
|
2,065,000 |
2,065,000 |
0.00 |
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
Financial Solutions Advisory Group, Inc.
|
|
27,431 |
|
| 2026-06-01 |
13F-HR |
PRTA
/ Prothena
|
Flagship Wealth Advisors, Llc
|
1,500 |
0 |
-100.00 |
| 2026-06-01 |
13F-HR/A |
INSM
/ Insmed
|
Nwi Management Lp
|
988,460 |
1,014,000 |
2.58 |
| 2026-06-01 |
13F-HR |
MRK
/ Merck
|
Integrated Investment Consultants, LLC
|
28,816 |
27,551 |
-4.39 |
| 2026-06-01 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Integrated Investment Consultants, LLC
|
15,566 |
15,841 |
1.77 |
| 2026-06-01 |
13F-HR/A |
COGT
/ Cogent Biosciences
|
Nwi Management Lp
|
241,671 |
241,671 |
0.00 |
| 2026-06-01 |
13F-HR |
NVO
/ Novo Nordisk A
|
Financial Solutions Advisory Group, Inc.
|
|
17,177 |
|
| 2026-06-01 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Caerus Investment Advisors, LLC
|
33,882 |
23,217 |
-31.48 |
| 2026-06-01 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
First Nebraska Trust Co
|
|
10,907 |
|
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Concorde Asset Management, LLC
|
2,763 |
2,563 |
-7.24 |
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
First Nebraska Trust Co
|
|
7,118 |
|
| 2026-06-01 |
13F-HR |
MRK
/ Merck
|
Financial Solutions Advisory Group, Inc.
|
|
5,069 |
|
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
First Nebraska Trust Co
|
|
105,768 |
|
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
Caerus Investment Advisors, LLC
|
14,675 |
0 |
-100.00 |
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Financial Solutions Advisory Group, Inc.
|
|
9,761 |
|
| 2026-06-01 |
13F-HR |
UTHR
/ United Therapeutics
|
Caerus Investment Advisors, LLC
|
1,464 |
470 |
-67.90 |
| 2026-06-01 |
13F-HR |
ZTS
/ Zoetis
|
Financial Solutions Advisory Group, Inc.
|
|
8,481 |
|
| 2026-06-01 |
13F-HR |
MRK
/ Merck
|
Flagship Wealth Advisors, Llc
|
1,362 |
699 |
-48.68 |
| 2026-06-01 |
13F-HR |
GOSS
/ Gossamer Bio
|
Caerus Investment Advisors, LLC
|
|
11,839 |
|
| 2026-06-01 |
13F-HR |
ALDX
/ Aldeyra Therapeutics
|
Caerus Investment Advisors, LLC
|
|
11,455 |
|
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Flagship Wealth Advisors, Llc
|
4,997 |
2,844 |
-43.09 |
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Foguth Wealth Management, LLC.
|
|
1,691 |
|
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
Flagship Wealth Advisors, Llc
|
14,311 |
15,831 |
10.62 |
| 2026-06-01 |
SCHEDULE 13D |
DRMA
/ Dermata Therapeutics
|
Kyri K. Van Hoose
|
|
384,352 |
|
| 2026-06-01 |
13F-HR/A |
COGT
/ Cogent Biosciences
|
Nwi Management Lp
|
|
241,671 |
|
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Integrated Investment Consultants, LLC
|
14,252 |
14,195 |
-0.40 |
| 2026-06-01 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
First Nebraska Trust Co
|
|
1,812 |
|
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
Concorde Asset Management, LLC
|
0 |
8,455 |
|
| 2026-06-01 |
13F-HR/A |
INSM
/ Insmed
|
Nwi Management Lp
|
1,021,000 |
988,460 |
-3.19 |
| 2026-06-01 |
13F-HR |
MRK
/ Merck
|
First Nebraska Trust Co
|
|
104,203 |
|
| 2026-06-01 |
13F-HR |
PFE
/ Pfizer
|
Integrated Investment Consultants, LLC
|
51,012 |
55,332 |
8.47 |
| 2026-06-01 |
13F-HR |
ABBV
/ AbbVie
|
Dala Group, LLC
|
|
1,364 |
|
| 2026-06-01 |
13F-HR |
MRK
/ Merck
|
Caerus Investment Advisors, LLC
|
18,585 |
18,563 |
-0.12 |
| 2026-06-01 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Flagship Wealth Advisors, Llc
|
7,234 |
6,608 |
-8.65 |
| 2026-05-29 |
13F-HR |
VRTX
/ Vertex Pharmaceuticals
|
Asset Dedication, LLC
|
294 |
237 |
-19.39 |
| 2026-05-29 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Keel Point, LLC
|
10,158 |
7,738 |
-23.82 |
| 2026-05-29 |
13F-HR/A |
SVRA
/ Savara
|
Perceptive Advisors Llc
|
2,400,000 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Ipsen Advisor Group LLC
|
11,160 |
11,131 |
-0.26 |
| 2026-05-29 |
13F-HR/A |
ALDX
/ Aldeyra Therapeutics
|
Perceptive Advisors Llc
|
4,185,632 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Roehl & Yi Investment Advisors, LLC
|
2,748 |
2,893 |
5.28 |
| 2026-05-29 |
13F-HR/A |
CTMX
/ CytomX Therapeutics
|
Perceptive Advisors Llc
|
9,680,185 |
10,098,824 |
4.32 |
| 2026-05-29 |
13F-HR/A |
EOLS
/ Evolus
|
Perceptive Advisors Llc
|
0 |
1,286,862 |
|
| 2026-05-29 |
13F-HR/A |
OCS
/ Oculis Holding
|
Perceptive Advisors Llc
|
493,827 |
493,827 |
0.00 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Asset Dedication, LLC
|
18,815 |
16,841 |
-10.49 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Roehl & Yi Investment Advisors, LLC
|
6,125 |
4,600 |
-24.90 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Roehl & Yi Investment Advisors, LLC
|
4,600 |
4,572 |
-0.61 |
| 2026-05-29 |
13F-HR |
ZTS
/ Zoetis
|
Keel Point, LLC
|
3,015 |
2,622 |
-13.03 |
| 2026-05-29 |
13F-HR/A |
MRK
/ Merck
|
Ramiah Investment Group
|
4,326 |
4,580 |
5.87 |
| 2026-05-29 |
13F-HR/A |
MRK
/ Merck
|
Ramiah Investment Group
|
5,111 |
3,824 |
-25.18 |
| 2026-05-29 |
13F-HR/A |
MRK
/ Merck
|
Ramiah Investment Group
|
5,517 |
5,111 |
-7.36 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Asset Dedication, LLC
|
428 |
328 |
-23.36 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Ramiah Investment Group
|
0 |
2,284 |
|
| 2026-05-29 |
SCHEDULE 13G |
BBIO
/ BridgeBio Pharma
|
Farallon Capital Partners, L.P.
|
|
10,226,063 |
|
| 2026-05-29 |
13F-HR/A |
COGT
/ Cogent Biosciences
|
Perceptive Advisors Llc
|
121,082 |
121,082 |
0.00 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Roehl & Yi Investment Advisors, LLC
|
|
2,748 |
|
| 2026-05-29 |
13F-HR |
NVO
/ Novo Nordisk A
|
Roehl & Yi Investment Advisors, LLC
|
|
12,674 |
|
| 2026-05-29 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt
|
Asset Dedication, LLC
|
2,949 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
BMY
/ Bristol-Myers Squibb
|
Ramiah Investment Group
|
4,210 |
4,008 |
-4.80 |
| 2026-05-29 |
13F-HR/A |
TNGX
/ Tango Therapeutics
|
Perceptive Advisors Llc
|
513,035 |
808,153 |
57.52 |
| 2026-05-29 |
13F-HR |
LGVN
/ Longeveron
|
Asset Dedication, LLC
|
|
10,500 |
|
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
893 |
970 |
8.62 |
| 2026-05-29 |
13F-HR |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
1,147 |
893 |
-22.14 |
| 2026-05-29 |
13F-HR/A |
DAWN
/ Day One Biopharmaceuticals
|
Perceptive Advisors Llc
|
0 |
1,755,799 |
|
| 2026-05-29 |
SCHEDULE 13D/A |
GRTX
/ Galera Therapeutics
|
Emerald Bioventures, LLC
|
40,216,160 |
61,029,978 |
51.75 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Roehl & Yi Investment Advisors, LLC
|
2,893 |
2,893 |
0.00 |
| 2026-05-29 |
13F-HR/A |
BHVN
/ Biohaven
|
Perceptive Advisors Llc
|
500,000 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
CNTB
/ Connect Biopharma Holdings
|
Perceptive Advisors Llc
|
792,696 |
792,696 |
0.00 |
| 2026-05-29 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt
|
Keel Point, LLC
|
|
2,828 |
|
| 2026-05-29 |
13F-HR |
UTHR
/ United Therapeutics
|
Keel Point, LLC
|
545 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
NVO
/ Novo Nordisk A
|
Asset Dedication, LLC
|
1,755 |
1,605 |
-8.55 |
| 2026-05-29 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Roehl & Yi Investment Advisors, LLC
|
|
3,499 |
|
| 2026-05-29 |
13F-HR |
PRTA
/ Prothena
|
Asset Dedication, LLC
|
184 |
184 |
0.00 |
| 2026-05-29 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Asset Dedication, LLC
|
4,336 |
4,355 |
0.44 |
| 2026-05-29 |
13F-HR |
NVO
/ Novo Nordisk A
|
Roehl & Yi Investment Advisors, LLC
|
12,674 |
13,069 |
3.12 |
| 2026-05-29 |
13F-HR/A |
CNTA
/ Centessa Pharmaceuticals plc - Depositary Receipt
|
Perceptive Advisors Llc
|
2,917,634 |
5,258,903 |
80.25 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
2,221 |
1,861 |
-16.21 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
1,044 |
969 |
-7.18 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
2,785 |
2,221 |
-20.25 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
3,143 |
2,925 |
-6.94 |
| 2026-05-29 |
13F-HR |
VRTX
/ Vertex Pharmaceuticals
|
Keel Point, LLC
|
1,216 |
947 |
-22.12 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
4,978 |
4,273 |
-14.16 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
2,925 |
3,054 |
4.41 |
| 2026-05-29 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Roehl & Yi Investment Advisors, LLC
|
3,499 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
BMY
/ Bristol-Myers Squibb
|
Ramiah Investment Group
|
0 |
0 |
|
| 2026-05-29 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt
|
Keel Point, LLC
|
10,452 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
NVO
/ Novo Nordisk A
|
Keel Point, LLC
|
8,861 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
NVO
/ Novo Nordisk A
|
Roehl & Yi Investment Advisors, LLC
|
13,069 |
17,361 |
32.84 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Keel Point, LLC
|
8,081 |
6,015 |
-25.57 |
| 2026-05-29 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
Roehl & Yi Investment Advisors, LLC
|
2,893 |
2,740 |
-5.29 |
| 2026-05-29 |
13F-HR/A |
RYTM
/ Rhythm Pharmaceuticals
|
Perceptive Advisors Llc
|
2,546,391 |
2,373,795 |
-6.78 |
| 2026-05-29 |
13F-HR/A |
PRAX
/ Praxis Precision Medicines
|
Perceptive Advisors Llc
|
1,995,986 |
2,035,986 |
2.00 |
| 2026-05-29 |
13F-HR/A |
ENSC
/ Ensysce Biosciences
|
Perceptive Advisors Llc
|
86,666 |
86,666 |
0.00 |
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Keel Point, LLC
|
20,289 |
16,556 |
-18.40 |
| 2026-05-29 |
13F-HR/A |
IRON
/ Disc Medicine
|
Perceptive Advisors Llc
|
450,743 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
NUVL
/ Nuvalent
|
Perceptive Advisors Llc
|
1,665,105 |
1,580,505 |
-5.08 |
| 2026-05-29 |
13F-HR/A |
IMMX
/ Immix Biopharma
|
Perceptive Advisors Llc
|
338,941 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Roehl & Yi Investment Advisors, LLC
|
6,008 |
6,125 |
1.95 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
3,359 |
2,785 |
-17.09 |
| 2026-05-29 |
13F-HR/A |
MRK
/ Merck
|
Ramiah Investment Group
|
5,271 |
5,517 |
4.67 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Ramiah Investment Group
|
4,580 |
5,271 |
15.09 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Roehl & Yi Investment Advisors, LLC
|
|
6,008 |
|
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Peak Planning Group, LLC
|
|
2,506 |
|
| 2026-05-29 |
13F-HR/A |
ABBV
/ AbbVie
|
Ramiah Investment Group
|
2,284 |
2,351 |
2.93 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Roehl & Yi Investment Advisors, LLC
|
|
2,295 |
|
| 2026-05-29 |
13F-HR/A |
ABBV
/ AbbVie
|
Ramiah Investment Group
|
2,351 |
2,031 |
-13.61 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Roehl & Yi Investment Advisors, LLC
|
2,390 |
2,326 |
-2.68 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,930 |
1,930 |
0.00 |
| 2026-05-29 |
13F-HR/A |
GOSS
/ Gossamer Bio
|
Perceptive Advisors Llc
|
3,139,669 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Roehl & Yi Investment Advisors, LLC
|
2,295 |
2,390 |
4.14 |
| 2026-05-29 |
13F-HR/A |
SDGR
/ Schrödinger
|
Perceptive Advisors Llc
|
202,400 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
ABBV
/ AbbVie
|
Ramiah Investment Group
|
2,031 |
1,968 |
-3.10 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
3,054 |
3,359 |
9.99 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,980 |
1,950 |
-1.52 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Peak Planning Group, LLC
|
|
3,823 |
|
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,950 |
1,930 |
-1.03 |
| 2026-05-29 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt
|
Asset Dedication, LLC
|
|
1,373 |
|
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Lavelle Capital Lp
|
|
3,650 |
|
| 2026-05-29 |
13F-HR/A |
BMY
/ Bristol-Myers Squibb
|
Ramiah Investment Group
|
0 |
4,210 |
|
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Roehl & Yi Investment Advisors, LLC
|
34,917 |
35,028 |
0.32 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Asset Dedication, LLC
|
10,716 |
8,960 |
-16.39 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,930 |
1,930 |
0.00 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Keel Point, LLC
|
11,830 |
10,907 |
-7.80 |
| 2026-05-29 |
13F-HR/A |
IRD
/ Opus Genetics
|
Perceptive Advisors Llc
|
4,325,000 |
1,835,842 |
-57.55 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
1,051 |
1,147 |
9.13 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
970 |
1,044 |
7.63 |
| 2026-05-29 |
13F-HR/A |
PTN
/ Palatin Technologies
|
Perceptive Advisors Llc
|
70,000 |
61,945 |
-11.51 |
| 2026-05-29 |
13F-HR |
ZTS
/ Zoetis
|
Roehl & Yi Investment Advisors, LLC
|
|
1,448 |
|
| 2026-05-29 |
13F-HR |
ZTS
/ Zoetis
|
Asset Dedication, LLC
|
64 |
64 |
0.00 |
| 2026-05-29 |
13F-HR/A |
VRDN
/ Viridian Therapeutics
|
Perceptive Advisors Llc
|
3,042,703 |
1,170,829 |
-61.52 |
| 2026-05-29 |
13F-HR |
ZTS
/ Zoetis
|
Roehl & Yi Investment Advisors, LLC
|
1,448 |
1,396 |
-3.59 |
| 2026-05-29 |
13F-HR |
ZTS
/ Zoetis
|
Roehl & Yi Investment Advisors, LLC
|
1,396 |
2,426 |
73.78 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,930 |
1,930 |
0.00 |
| 2026-05-29 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Ramiah Investment Group
|
4,273 |
3,143 |
-26.45 |
| 2026-05-29 |
13F-HR/A |
ROIV
/ Roivant Sciences
|
Perceptive Advisors Llc
|
7,985,461 |
8,285,461 |
3.76 |
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Asset Dedication, LLC
|
23,756 |
20,951 |
-11.81 |
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Lavelle Capital Lp
|
|
35,750 |
|
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Roehl & Yi Investment Advisors, LLC
|
|
24,927 |
|
| 2026-05-29 |
SCHEDULE 13G |
XBIO
/ Xenetic Biosciences
|
MJL Manager LLC
|
|
126,741 |
|
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Roehl & Yi Investment Advisors, LLC
|
24,927 |
34,917 |
40.08 |
| 2026-05-29 |
13F-HR |
PFE
/ Pfizer
|
Roehl & Yi Investment Advisors, LLC
|
35,028 |
36,473 |
4.13 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
|
1,980 |
|
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,980 |
1,980 |
0.00 |
| 2026-05-29 |
13F-HR/A |
CAPR
/ Capricor Therapeutics
|
Perceptive Advisors Llc
|
242,100 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
MRK
/ Merck
|
Keel Point, LLC
|
51,571 |
39,387 |
-23.63 |
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Mullaney, Keating & Wright, Inc.
|
1,930 |
1,930 |
0.00 |
| 2026-05-29 |
13F-HR/A |
ATXS
/ Astria Therapeutics
|
Perceptive Advisors Llc
|
6,485,420 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
CPIX
/ Cumberland Pharmaceuticals
|
Perceptive Advisors Llc
|
341,087 |
196,978 |
-42.25 |
| 2026-05-29 |
13F-HR |
GTBP
/ GT Biopharma
|
Keel Point, LLC
|
|
20,768 |
|
| 2026-05-29 |
13F-HR |
ABBV
/ AbbVie
|
Roehl & Yi Investment Advisors, LLC
|
2,326 |
2,327 |
0.04 |
| 2026-05-29 |
13F-HR/A |
AVTX
/ Avalo Therapeutics
|
Perceptive Advisors Llc
|
139,667 |
139,667 |
0.00 |
| 2026-05-29 |
13F-HR/A |
IONS
/ Ionis Pharmaceuticals
|
Perceptive Advisors Llc
|
0 |
504,000 |
|
| 2026-05-29 |
13F-HR/A |
SYRE
/ Spyre Therapeutics
|
Perceptive Advisors Llc
|
3,069,225 |
3,783,225 |
23.26 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Ipsen Advisor Group LLC
|
4,642 |
4,686 |
0.95 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
1,899 |
1,899 |
0.00 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
1,899 |
1,899 |
0.00 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Roehl & Yi Investment Advisors, LLC
|
|
838 |
|
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Roehl & Yi Investment Advisors, LLC
|
909 |
898 |
-1.21 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Roehl & Yi Investment Advisors, LLC
|
|
3,593 |
|
| 2026-05-29 |
13F-HR/A |
NRIX
/ Nurix Therapeutics
|
Perceptive Advisors Llc
|
3,555,877 |
3,710,877 |
4.36 |
| 2026-05-29 |
13F-HR/A |
OCUL
/ Ocular Therapeutix
|
Perceptive Advisors Llc
|
|
500,000 |
|
| 2026-05-29 |
13F-HR/A |
AQST
/ Aquestive Therapeutics
|
Perceptive Advisors Llc
|
747,193 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
SNY
/ Sanofi - Depositary Receipt
|
Asset Dedication, LLC
|
1,812 |
6 |
-99.67 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Roehl & Yi Investment Advisors, LLC
|
14,870 |
26,282 |
76.75 |
| 2026-05-29 |
13F-HR/A |
AXSM
/ Axsome Therapeutics
|
Perceptive Advisors Llc
|
148,900 |
149,950 |
0.71 |
| 2026-05-29 |
13F-HR/A |
PEPG
/ PepGen
|
Perceptive Advisors Llc
|
829,870 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Keel Point, LLC
|
32,376 |
25,357 |
-21.68 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Roehl & Yi Investment Advisors, LLC
|
3,593 |
3,672 |
2.20 |
| 2026-05-29 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Ramiah Investment Group
|
3,105 |
3,257 |
4.90 |
| 2026-05-29 |
SCHEDULE 13G |
AVTX
/ Avalo Therapeutics
|
Deep Track Capital, LP
|
0 |
3,055,027 |
|
| 2026-05-29 |
13F-HR/A |
FOLD
/ Amicus Therapeutics
|
Perceptive Advisors Llc
|
6,370,851 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Ramiah Investment Group
|
|
3,105 |
|
| 2026-05-29 |
13F-HR/A |
EDSA
/ Edesa Biotech
|
Perceptive Advisors Llc
|
|
563,239 |
|
| 2026-05-29 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Ramiah Investment Group
|
2,935 |
1,928 |
-34.31 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Roehl & Yi Investment Advisors, LLC
|
15,199 |
15,028 |
-1.13 |
| 2026-05-29 |
13F-HR |
NNVC
/ NanoViricides
|
Asset Dedication, LLC
|
1,450 |
1,450 |
0.00 |
| 2026-05-29 |
13F-HR/A |
ANRO
/ Alto Neuroscience
|
Perceptive Advisors Llc
|
1,784,393 |
2,009,893 |
12.64 |
| 2026-05-29 |
13F-HR/A |
DRUG
/ Bright Minds Biosciences
|
Perceptive Advisors Llc
|
449,290 |
377,544 |
-15.97 |
| 2026-05-29 |
13F-HR/A |
PHAT
/ Phathom Pharmaceuticals
|
Perceptive Advisors Llc
|
|
925,000 |
|
| 2026-05-29 |
13F-HR/A |
ZYME
/ Zymeworks
|
Perceptive Advisors Llc
|
3,261,850 |
3,510,078 |
7.61 |
| 2026-05-29 |
13F-HR |
STTK
/ Shattuck Labs
|
Keel Point, LLC
|
14,270 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
APLS
/ Apellis Pharmaceuticals
|
Perceptive Advisors Llc
|
0 |
80,956 |
|
| 2026-05-29 |
13F-HR/A |
XENE
/ Xenon Pharmaceuticals
|
Perceptive Advisors Llc
|
200,791 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Asset Dedication, LLC
|
4,336 |
4,073 |
-6.07 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Roehl & Yi Investment Advisors, LLC
|
898 |
898 |
0.00 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Roehl & Yi Investment Advisors, LLC
|
838 |
909 |
8.47 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Lavelle Capital Lp
|
|
197 |
|
| 2026-05-29 |
13F-HR/A |
CORT
/ Corcept Therapeutics
|
Perceptive Advisors Llc
|
0 |
50,000 |
|
| 2026-05-29 |
13F-HR |
AXSM
/ Axsome Therapeutics
|
Keel Point, LLC
|
1,181 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
TENX
/ Tenax Therapeutics
|
Perceptive Advisors Llc
|
439,142 |
1,447,782 |
229.68 |
| 2026-05-29 |
13F-HR/A |
RAPT
/ RAPT Therapeutics
|
Perceptive Advisors Llc
|
825,890 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
OLMA
/ Olema Pharmaceuticals
|
Perceptive Advisors Llc
|
165,713 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR/A |
EWTX
/ Edgewise Therapeutics
|
Perceptive Advisors Llc
|
4,457,974 |
4,423,974 |
-0.76 |
| 2026-05-29 |
13F-HR |
VTRS
/ Viatris
|
Asset Dedication, LLC
|
1,215 |
1,058 |
-12.92 |
| 2026-05-29 |
13F-HR/A |
GLTO
/ Damora Therapeutics
|
Perceptive Advisors Llc
|
|
1,223,000 |
|
| 2026-05-29 |
13F-HR |
VTYX
/ Ventyx Biosciences
|
Asset Dedication, LLC
|
4,301 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
OGN
/ Organon
|
Asset Dedication, LLC
|
229 |
229 |
0.00 |
| 2026-05-29 |
13F-HR |
LLY
/ Eli Lilly and
|
Keel Point, LLC
|
4,085 |
2,671 |
-34.61 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Roehl & Yi Investment Advisors, LLC
|
3,645 |
4,183 |
14.76 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Asset Dedication, LLC
|
16,965 |
15,688 |
-7.53 |
| 2026-05-29 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Ramiah Investment Group
|
3,257 |
2,935 |
-9.89 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
1,899 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Roehl & Yi Investment Advisors, LLC
|
3,672 |
3,645 |
-0.74 |
| 2026-05-29 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Roehl & Yi Investment Advisors, LLC
|
15,028 |
14,870 |
-1.05 |
| 2026-05-29 |
13F-HR/A |
PTGX
/ Protagonist Therapeutics
|
Perceptive Advisors Llc
|
1,350,425 |
1,230,879 |
-8.85 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
1,919 |
1,899 |
-1.04 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Asset Dedication, LLC
|
8,863 |
6,923 |
-21.89 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
1,919 |
1,919 |
0.00 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Keel Point, LLC
|
9,177 |
6,333 |
-30.99 |
| 2026-05-29 |
13F-HR |
ALNY
/ Alnylam Pharmaceuticals
|
Asset Dedication, LLC
|
5 |
5 |
0.00 |
| 2026-05-29 |
13F-HR/A |
MIRM
/ Mirum Pharmaceuticals
|
Perceptive Advisors Llc
|
259,545 |
0 |
-100.00 |
| 2026-05-29 |
13F-HR |
ABT
/ Abbott Laboratories
|
Mullaney, Keating & Wright, Inc.
|
|
1,919 |
|